Phylo (video game)

Organigram Provides Corporate Update

Retrieved on: 
Wednesday, October 18, 2023
Alternative Medicine, Cannabis, Retail, Health, Tobacco, Natural Resources, Food, Beverage, F1 hybrid, BAT, Lac, Energy, NB Power, Organizational chart, Edible, Partnership, NB, THC, ERP, Silviculture, Phylo (video game)

Investment and Collaboration with U.S. Based Phylos Biosciences

Key Points: 
  • Investment and Collaboration with U.S. Based Phylos Biosciences
    Monetizing the investment in Phylos Bioscience continues to be a key focus as Organigram moves towards seed-based production in its Moncton facility.
  • This investment in automated pre-roll technology has helped Organigram secure the #2 position in the category.
  • Clones are now onsite, and Organigram expects to see the first harvest out of that facility by early December.
  • As previously disclosed, Organigram has recently changed its fiscal year end to better reflect its operating and financial cycles.

Organigram Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower

Retrieved on: 
Monday, August 28, 2023
Cannabis, Natural Resources, Trailblazer, THCV, Senior, Communication, Cannabinoid, Innovation, Multimedia, Appetite, Marketing, Terpene, Organizational chart, OGI, CBD, TSX, THC, Flavonoid, CO2, Video game, Drug, Tea, Phylo (video game)

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to launch its first range of whole-flower derived THCV products through the Company’s popular SHRED and newly re-launched Trailblazer brands.

Key Points: 
  • Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to launch its first range of whole-flower derived THCV products through the Company’s popular SHRED and newly re-launched Trailblazer brands.
  • Through this investment, Organigram cultivates and extracts THCV in-house in its state-of-the-art Moncton facility and is currently believed to be the only Canadian licensed producer (LP) to do so.
  • Our products are naturally (and not synthetically) derived, not created through chemical processes in a laboratory setting.
  • By harnessing the power of THCV through our strategic investment, we are reshaping the cannabis experience for consumers,” says Megan McCrae, Senior Vice President of Marketing and Communications at Organigram.

Organigram Reports Third Quarter Fiscal 2023 Results

Retrieved on: 
Friday, July 14, 2023
Cannabis, Natural Resources, Purchasing, THCV, Holy Mountain, Drink, Aerosol, Seed, Genetics, Biolab, Ontario Cannabis Retail Corporation, Cannabinoid, Emulsion, Research, WHC, CBG, Public expenditure, PDC, Data, Investment, Power purchase agreement, CBD, Milk, R, THC, Fiscal, Drug, Tea, Fine chemical, Pharmaceutical industry, Phylo (video game), Organizational chart

Q3 Fiscal 2023 saw the introduction of a record-breaking 28 new SKUs to the market for Organigram.

Key Points: 
  • Q3 Fiscal 2023 saw the introduction of a record-breaking 28 new SKUs to the market for Organigram.
  • Organigram has introduced one of its newest high THC cultivars, Tropical Reign, in large format 28g bags, under its Holy Mountain brand.
  • For Fiscal 2023 the Company had approximately $10 million in remaining capex committed to the three facilities.
  • Organigram believes its capital position is healthy and that there is sufficient liquidity available for the near to medium term.

Organigram Makes First Strategic U.S. Investment in Phylos Bioscience to Commercialize THCV and Scale Seed Based Production

Retrieved on: 
Thursday, May 25, 2023
Alternative Medicine, Cannabis, Retail, Health, Natural Resources, Pharmaceutical, THCV, PIK, International, Convertible, Seed, Genetics, Breeding, Cannabinoid, Deficit spending, Multimedia, Science, Loan agreement, Initial, F1, Patent, OGI, TSX, THC, Agriculture, Security (finance), Phylo (video game), Organizational chart

In the future, subject to receipt of any required approvals and permits, Organigram intends to export THCV products to select legal international markets.

Key Points: 
  • In the future, subject to receipt of any required approvals and permits, Organigram intends to export THCV products to select legal international markets.
  • View the full release here: https://www.businesswire.com/news/home/20230525005730/en/
    “This marks Organigram’s first U.S. investment and advances its strategy to create cost-effective, innovative cannabis products that consumers want.
  • F1 Hybrid Phylos Production-Ready Seed™ enables direct sowing of cannabis seeds compared to today's clone-based production.
  • Seed-based production offers the economic advantages of reduced labour while recapturing existing facility footprint currently used by Organigram for raising clones for production.

New Generation of Cannabis Seed Ensures Quality, Consistency, and Uniformity for Commercial Growers

Retrieved on: 
Wednesday, April 27, 2022
Breeding, Seed, Marker beacon, PST, Plant, Research, Growth, Efficiency, Common, Environment, Solution, Cannabis, F1, Data science, Agriculture, Silviculture, Coffee, Phylo (video game)

PORTLAND, Ore., April 27, 2022 /PRNewswire/ -- Modern crop science company Phylos®, is providing a long-awaited solution for commercial growers looking for uniformity, input reduction, and risk mitigation for large-scale cannabis and hemp production — highly-optimized production-ready F1 hybrid seed.

Key Points: 
  • Now, growers can directly sow seeds with confidence that the resulting plants will be reliably consistent and uniform.
  • "We're excited that our production-ready seed lines are getting into the hands of growers.
  • Traditionally, growers have opted to use clonal varieties in commercial cannabis operations.
  • Through data science and the optimization of cannabis genetics, Phylos is making profitable and sustainable large-scale cannabis production a reality for commercial growers everywhere.

Cannabis Study Reveals Optimal Canopy Density for Highest Yield, Efficiency and Profitability in Greenhouse Growing Environment

Retrieved on: 
Wednesday, February 16, 2022
Cannabis, Collection, Plant, Research, Terpene, Breeding, Flower, Biomass, Cannabinoid, Efficiency, Particle-size distribution, Electricity, PPR, THC, Coffee, Flowers, Phylo (video game)

The purpose of this study was to establish the effect of plant density on biomass, extraction yield, cannabinoids, terpenes, and other traits.

Key Points: 
  • The purpose of this study was to establish the effect of plant density on biomass, extraction yield, cannabinoids, terpenes, and other traits.
  • Findings from this study highlight how optimizing density treatments can improve crop yield, efficiency, and sustainability as well as answer the question,"how dense should my canopy be to maximize yield and profit from my production" often asked by cannabis and hemp growers.
  • "The density trial demonstrates a huge economic advantage achieved from a high density production treatment," says John McFerson, Vice President of Breeding at Phylos.
  • For more information on their day-neutral cannabis genetics or any questions for the research team, please contact [email protected] .

Phylos Closes $7.6 Million in Funding to Scale Market-Validated Cannabis and Hemp Genetics and Unveils New Executive Team to Drive Industry Innovation

Retrieved on: 
Tuesday, February 1, 2022
CEO, Breeding, IP, PPR, Genomics, Technology, Research, Marker beacon, Industry, Movement, F1, Genetics, Partnership, Solution, Accomplice, Drug, Agriculture, Cannabis, Phylo (video game)

Funds will be used in part to expand sales and marketing efforts for Phylos' market-validated Cannabis and hemp genetics.

Key Points: 
  • Funds will be used in part to expand sales and marketing efforts for Phylos' market-validated Cannabis and hemp genetics.
  • Mina Mishrikey, Senior Partner at Merida will be joining the Phylos board of directors.
  • Leading towards industry growth and scalability, the new executive team will leverage proprietary research and technology to drive innovation in hemp and Cannabis science and breeding.
  • We are confident that Phylos is at the forefront of this movement towards a healthier plant and a more sustainable industry."

Aktis Oncology Expands Leadership Team with Two Strategic Hires

Retrieved on: 
Tuesday, January 18, 2022
Research, CMC, PET, Disease, Biotechnology, AVID, University, Growth, Protein engineering, Alzheimer's disease, Organic chemistry, Protein design, Therapy, Company, Washington College, Associate, Radiopharmaceutical, Doctor of Philosophy, Phylo (video game), MIT, Biochemistry, Multimedia, Bristol Myers Squibb, Engineering, Chemist, Eli Lilly and Company, Drug discovery, Avid Radiopharmaceuticals, Fragment-based lead discovery, Management, Medical imaging, Chemistry, Biology, Olympiaki Akti

"I am excited to welcome Tyler and Daa to the Aktis Oncology team, as I believe their expertise across key aspects of research and development will prove to be invaluable assets to our capabilities and growth of our pipeline," said Matthew Roden, PhD, President, and Chief Executive Officer of Aktis Oncology.

Key Points: 
  • "I am excited to welcome Tyler and Daa to the Aktis Oncology team, as I believe their expertise across key aspects of research and development will prove to be invaluable assets to our capabilities and growth of our pipeline," said Matthew Roden, PhD, President, and Chief Executive Officer of Aktis Oncology.
  • "These additions to our leadership team will help us further develop our programs as we work towards realizing the curative power of alpha radiopharmaceuticals for mainstream cancer care."
  • Dr. Benedum's role at Aktis will focus on developing radiopharmaceuticals, establishing a manufacturing network, and oversight of CMC regulatory.
  • To learn more about Aktis Oncology, visit www.aktisoncology.com .

Phylos Named in mg Magazine's 50 Best Companies to Work for in Cannabis

Retrieved on: 
Tuesday, December 28, 2021
COVID-19, Marker beacon, Health, Growth, Industry, Patent, Business operations, PPR, Safety, Learning, COVID, Indeed, Happiness, Genetics, Culture, CEO, Management, Phylo (video game), Cannabis

PORTLAND, Ore., Dec. 28, 2021 /PRNewswire/ -- Phylos , a modern crop science company developing advanced Cannabis and hemp genetics, was selected in mg Magazine's 50 Best Companies to Work for in Cannabis .

Key Points: 
  • PORTLAND, Ore., Dec. 28, 2021 /PRNewswire/ -- Phylos , a modern crop science company developing advanced Cannabis and hemp genetics, was selected in mg Magazine's 50 Best Companies to Work for in Cannabis .
  • "To bring the best recommendations, tools, and services to growers we have to work with the best people in the industry.
  • Phylos is known for delivering best-in-class genetics and support, but at its core Phylos is just an incredible team of caring people."
  • A culture that is both collaborative and curious has been a key driver in Phylos' innovation in Cannabis genetics.